Z7R-32429-45620
2 vaccinations
3 coded responses
24 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 378 / TN
- Registered
- 2021-01-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-27
Registered in v-safe
-
2021-01-27
Dose 1 — Moderna
- 2021-01-27
-
2021-01-28
Survey response — days 1–6 daily, dose 1MedDRA: Heart rate increased — Feeling: Good · Site: PainFree text: Yesterday after I filled out the Vsafe, I noticed increased resting heart rate- it was running around 100 while I was inactive and just sitting. After 2 hours, resting rate came down to my regular resting heart rate of 70-80. Blood pressure was fine when it was checked. No other symptoms.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-29
- 2021-01-30
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-10
- 2021-02-17
-
2021-02-24
Dose 2 — Moderna
- 2021-02-24
-
2021-02-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness · Fever · Chills, Headache, Joint pains, Fatigue or tiredness, Nausea · Be unable to workAdult check-in
-
2021-02-26
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
- 2021-02-27
- 2021-02-28
- 2021-03-01
- 2021-03-02
- 2021-03-03
-
2021-03-10
Survey response — day 14, dose 2MedDRA: Oligomenorrhoea — Feeling: FairFree text: Menstrual period lasting >3 weeks.Began on 2/12/2021.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-17
- 2021-03-24
- 2021-04-02
- 2021-04-07
-
2021-05-26
Survey response — 3 months, dose 2MedDRA: Endometrial thickening, Heavy menstrual bleeding — Feeling: GoodFree text: Thickened endometrial tissue and extended periods lasting 6 weeks at a time. I am following up with a gynecologist.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-27 | Moderna | |
| 2 | 2021-02-24 | Moderna |
Free text
Release 3 — days 1–6 daily, dose 1
Systemic reaction (other): Yesterday after I filled out the Vsafe, I noticed increased resting heart rate- it was running around 100 while I was inactive and just sitting. After 2 hours, resting rate came down to my regular resting heart rate of 70-80. Blood pressure was fine when it was checked. No other symptoms.
Release 5 — day 14, dose 2
Symptoms: Menstrual period lasting >3 weeks.Began on 2/12/2021.
Release 8 — 3 months, dose 2
Symptoms: Thickened endometrial tissue and extended periods lasting 6 weeks at a time. I am following up with a gynecologist.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Endometrial thickening | ✓ | ✓ | ✓ |
| SD | Heavy menstrual bleeding | ✓ | ✓ | ✓ |
| SD | Oligomenorrhoea | ✓ | ✓ | ✓ |
| SRO | Heart rate increased | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release